News

Post Date : 14/07/2016

College Written Exam 2016 (Council Meeting 14 July 2016)

Results of College Written Exam in Chemical Pathology and Clinical Microbiology & Infection 2016

EXAM NO. RESULT
E16206 PASS
E16207 FAIL
E16209 PASS
E16211 PASS

Candidates who failed in written exam cannot proceed further in Fellowship Assessment in 2016.

Passed candidates can proceed further in Fellowship Assessment in 2016.

Post Date : 18/04/2016

Dear Fellows and CMECPD Activities Organizers,

Kindly noted that the attendaance records for CMECPD activites are updated and please download the relevant attendance record form here.

Thank you very much for your attention.

Webmaster

18 April 2016

Post Date : 26/02/2016

Dear AP QAP members,

The urls of our QA Program are fixed.

If you failed to use the direct link on our new version of College website, ie QA Program on the Menu Bar (could be due to browser cache issue), kindly use the following classic QAP web page to enter the results of the HKCP-QAP QAP (AP) 2015 R2 with your usual password and workflow through the following urls

http://classic.hkcpath.org/

or direct url at

http://classic.hkcpath.org/qap/qap.htm

We will delay the deadline of submission by 2 week, ie. on 14 March 2016.

Sorry for the inconvenience caused.

Webmaster

Post Date : 22/09/2015

Fellowship Assessment:

Exam No.  Result

E15201      Pass
E15202      Fail
E15203      Pass
E15204      Fail
E15205      Pass
E15206      Fail
E15207      Fail
E15208      Fail
E15209      Pass
E15210      Pass
E15211      Pass
E15212      Pass
E15213      Pass
E15214      Pass
E15215      Pass
E15216      Fail
E15217      Fail
E15219      Fail
E15220      Fail
E15221      Pass
E15222      Pass

Membership Examination:

Exam No.  Result

E15101      Pass
E15102      Fail
E15103      Fail
E15104...
Post Date : 01/01/2015

Volume 10, Issue 1, January 2015

Dr. Anthony W.H. Chan

Associate Professor Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong

Introduction

Non-alcoholic fatty liver disease (NAFLD) is a serious global health problem and associated with over-nutrition and its related metabolic risk factors including central obesity, glucose intolerance, dyslipidaemia and hypertension. It is the most common metabolic liver disease worldwide and its prevalence in most Asian countries is similar to that in the States, Europe and Australia. About 10-45% of Asian population have NAFLD. With “westernized” sedentary lifestyle, the prevalence of NAFLD in general urban population in the mainland China is about 15%. NAFLD is even more prevalent in Hong Kong. Our recent study demonstrated...

Post Date : 02/11/2014

The 23:2 edition of College Newsletter is now ready: /newsletter 23:2

Index of this issue:

  • Message from the President
  • Featured article: Should we be thinking about revalidation or recertification of pathologists
  • Topical Update: Molecular Classification and Genetic Alterations of Diffuse Large B-cell Lymphoma
  • Report on Research Project funded by Chan Woon Cheung Education and Research Fund
  • Out of the Whitecoat: My Sake Journey
  • Obituary: Dr Rina WONG Kwai Ying
  • Obituary: Dr Joanna HO Chor Ying
  • Membership Examination and Fellowship Assessment results
  • Programme of the 23rd Annual General Meeting: 29/11/2014
  • International Pathology Day Exhibition: 5/11/2014 - 11/11/2014
Post Date : 17/09/2014

Fellowship Assessment:

Exam No. Result
AN14302 Fail
AN14304 Fail
AN14306 Fail
AN14307 Fail
AN14308 Pass
AN14309 Pass
AN14311 Pass
AN14313 Pass
AN14315 Pass
E14211 Fail
E14212 Pass
E14214 Fail
E14215 Pass
E14216 Fail

 

...
Post Date : 28/07/2014

Fellowship Assessment:

Exam No. Result
E14210 Fail
E14213 Fail

Membership Examination:

Exam No. Result
E14107 Fail
Post Date : 01/07/2014

Volume 9, Issue 2, July 2014

Dr CHOI Wai Lap

Department of Clinical Pathology Tuen Mun Hospital

Introduction

Diffuse large B-cell lymphoma (DLBCL) is the commonest subtype of non-Hodgkin lymphoma, accounting for about 30% to 40% of newly diagnosed non-Hodgkin lymphoma worldwide and in Hong Kong. DLBCL is heterogeneous in clinical presentation, morphology, immunophenotype, cytogenetics and prognos is. In the WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissues published in 2008, several specific clinicopathological entities of DLBCL have been recognized, while leaving the rest to DLBCL, not otherwise specified, which is by far the most prevalent entity among the large B-cell lymphomas. In the following discussion, the term DLBCL will be used interchangeably with DLBCL, not otherwise specified.

...